Xeris Pharmaceuticals Inc

NASDAQ:XERS   3:59:39 PM EDT
4.57
+0.25 (+5.79%)
4:44:59 PM EDT: $4.59 +0.02 (+0.44%)
Earnings Announcements

Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results And Corporate Highlights

Published: 11/09/2020 12:12 GMT
Xeris Pharmaceuticals Inc (XERS) - Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights.
Q3 Loss per Share $0.35.
Q3 Sales $9.4 Million.
Q3 Earnings per Share Estimate $-0.52 -- Refinitiv Ibes Data (analyst estimates).
Q3 Revenue Estimate $4.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $9.4 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $9.93 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.